PMID- 10598193 OWN - NLM STAT- MEDLINE DCOM- 20000104 LR - 20190915 IS - 0039-6060 (Print) IS - 0039-6060 (Linking) VI - 126 IP - 6 DP - 1999 Dec TI - Screening for MEN1 mutations in patients with atypical endocrine neoplasia. PG - 1097-103; discussion 1103-4 AB - BACKGROUND: Most patients from typical multiple endocrine neoplasia type 1 (MEN1) kindreds harbor mutations in the MEN-1 gene, MEN1. We hypothesized that some patients with atypical endocrine neoplasia would also have mutations in MEN1. METHODS: DNA sequencing analysis of mutations in the coding region of MEN1 was performed with genomic DNA obtained from peripheral blood lymphocytes in a total of 21 patients who had: typical MEN1 (n = 8), clinical features suggestive of MEN1 but without a family history of endocrinopathy (n = 7), and atypical endocrine neoplasia and a family history of endocrinopathy suggestive of MEN1 (n = 6). RESULTS: All 8 patients with typical MEN1 had mutations in MEN1. None of the 7 patients with features of MEN1, but without a family history of endocrinopathy, had a MEN1 mutation. In contrast, 4 of 6 patients with atypical endocrine neoplasia that included components of MEN1 and a family history of endocrinopathy had mutations in MEN1, including 2 patients with pheochromocytoma. CONCLUSIONS: Genomic mutations in MEN1 may frequently be identified in patients with atypical endocrine neoplasia, especially in the setting of a family history of endocrinopathy. Atypical presentations of MEN1 may include pheochromocytoma. FAU - Dackiw, A P AU - Dackiw AP AD - Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. FAU - Cote, G J AU - Cote GJ FAU - Fleming, J B AU - Fleming JB FAU - Schultz, P N AU - Schultz PN FAU - Stanford, P AU - Stanford P FAU - Vassilopoulou-Sellin, R AU - Vassilopoulou-Sellin R FAU - Evans, D B AU - Evans DB FAU - Gagel, R F AU - Gagel RF FAU - Lee, J E AU - Lee JE LA - eng PT - Journal Article PL - United States TA - Surgery JT - Surgery JID - 0417347 RN - 0 (MEN1 protein, human) RN - 0 (Neoplasm Proteins) RN - 0 (Proto-Oncogene Proteins) SB - IM MH - Adrenal Gland Neoplasms/diagnostic imaging/*genetics MH - DNA Mutational Analysis MH - Family Health MH - Female MH - *Genetic Testing MH - Humans MH - Male MH - Multiple Endocrine Neoplasia Type 1/diagnostic imaging/*genetics MH - Mutation MH - Neoplasm Proteins/*genetics MH - Pancreatic Neoplasms/diagnostic imaging/genetics MH - Pedigree MH - Pheochromocytoma/diagnostic imaging/*genetics MH - *Proto-Oncogene Proteins MH - Radiography MH - Restriction Mapping EDAT- 1999/12/22 00:00 MHDA- 1999/12/22 00:01 CRDT- 1999/12/22 00:00 PHST- 1999/12/22 00:00 [pubmed] PHST- 1999/12/22 00:01 [medline] PHST- 1999/12/22 00:00 [entrez] AID - S0039-6060(99)70067-X [pii] AID - 10.1067/msy.2099.101376 [doi] PST - ppublish SO - Surgery. 1999 Dec;126(6):1097-103; discussion 1103-4. doi: 10.1067/msy.2099.101376.